Website maintenance took place on Thursday 30 April 2026. If you experience any issues, please contact us.
AusPAR: Baricitinib
Australian Public Assessment Report
Device/Product Name
Olumiant
Active ingredients
Baricitinib
AusPAR Date
Published
Sponsor
Submission Number
PM-2019-05319-1-1
Submission Type
Extension of indications
Decision
Approved